Trial · NCT01609062
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Safety Evaluation | Entire Study Period, up to 192 weeks or ETV (early termination visit) | The primary outcome measure data is presented in more detail under the Adverse Events section. | participants | NUMBER |
| SECONDARY | 6-minute Walk Test (6MWT) | Baseline, Week 12, 24, and 52 | Modified Intent-to-Treat Analysis Set | meters | MEAN |
| SECONDARY | 3-minute Stair Climb Test (3MSCT) | Baseline, Week 12, 24, and 52 | Modified Intent-to-Treat Analysis Set | stairs/min | MEAN |
| SECONDARY | Respiratory Function Test (MVV and FVC) | Baseline, Week 12, 24, and 52 | Modified Intent-to-treat Analysis Set | Percent Change | MEAN |
| SECONDARY | Normalized Urine Keratan Sulfate (uKS) | Baseline, Week 12, 24, and 52 | Modified Intent-to-treat Analysis Set | Percent Change | MEAN |
| SECONDARY | Cardiopulmonary Exercise Testing (CPET) - Duration of Exercise | Baseline, Week 25 and 52 | A subset of mITT subjects who were scheduled to perform CPET | Percent Change | MEAN |
| SECONDARY | Cardiopulmonary Exercise Testing (CPET) - Peak Workload | Baseline, Week 25 and 52 | A subset of mITT subjects who were scheduled to perform CPET | Percent Change | MEAN |
| SECONDARY | Cardiopulmonary Exercise Testing (CPET) - O2 Pulse | Baseline, Week 25 and 52 | A subset of mITT subjects who were scheduled to perform CPET | Percent Change | MEAN |
| SECONDARY | Cardiopulmonary Exercise Testing (CPET) - Aerobic Efficiency | Baseline, Week 25 and 52 | A subset of mITT subjects who were scheduled to perform CPET | Percent Change | MEAN |
| SECONDARY | Muscle Strength Testing (MST) - Knee Extension Test | Baseline, Week 25 and 52 | Modified Intent-to-treat Analysis Set | Percent Change | MEAN |
| SECONDARY | Muscle Strength Testing (MST) - Knee Flexion Test | Baseline, Week 25 and 52 | Modified Intent-to-treat Analysis Set | Percent Change | MEAN |
| SECONDARY | Muscle Strength Testing (MST) - Elbow Flexion Test | Baseline, Week 25 and 52 | Modified Intent-to-treat Analysis Set | Percent Change | MEAN |
| SECONDARY | Adolescent Pediatric Pain Tool (APPT) - Pain Intensity | Baseline, Week 12, 24, and 52 | Modified Intent-to-treat | units on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01609062/outcomes